Guided Therapeutics completes warrant exchange; issues 4.825M shares for $980K cash

GUIDED THERAPEUTICS INC

Holders of 4.825M eligible warrants (22.7% of total) tendered; exchanged for restricted common stock at reduced exercise prices.
Exercise price for $0.65 warrants reduced to $0.25; for $0.50 warrants reduced to $0.20, generating $980K total cash proceeds.
After exchange, company has 91.5M shares outstanding; 16.4M eligible warrants remain, most expiring Sep–Oct 2026.
Remaining unexercised warrants held by participating holders have expiration extended by one year.
Shares issued under Section 3(a)(9) exemption; no commissions paid for solicitation.

item 1.01 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

GUIDED THERAPEUTICS INC issued 4,825,000 shares of common stock to holders of Eligible Warrants.

Security: common stock
Shares: 4,825,000 shares
Purchaser: holders of Eligible Warrants

Exact text from the filing

on March 2, 2026, the Company issued an aggregate of 4,825,000 shares of Common Stock to holders of Eligible Warrants.

View on SEC.gov

Browse all equity issuances →

GUIDED THERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001477932-26-001252

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.